“Sentinel or accomplice”: gut microbiota and microglia crosstalk in disorders of gut–brain interaction

Abstract

Abnormal brain–gut interaction is considered the core pathological mechanism behind the disorders of gut–brain interaction (DGBI), in which the intestinal microbiota plays an important role. Microglia are the “sentinels” of the central nervous system (CNS), which participate in tissue damage caused by traumatic brain injury, resist central infection and participate in neurogenesis, and are involved in the occurrence of various neurological diseases. With in-depth research on DGBI, we could find an interaction between the intestinal microbiota and microglia and that they are jointly involved in the occurrence of DGBI, especially in individuals with comorbidities of mental disorders, such as irritable bowel syndrome (IBS). This bidirectional regulation of microbiota and microglia provides a new direction for the treatment of DGBI. In this review, we focus on the role and underlying mechanism of the interaction between gut microbiota and microglia in DGBI, especially IBS, and the corresponding clinical application prospects and highlight its potential to treat DGBI in individuals with psychiatric comorbidities.

Keywords

gut microbiota / microglia / disorders of gut–brain interaction / irritable bowel syndrome

References

[1] Abdel-Haq R, Schlachetzki JCM, Glass CK et al. Microbiome-microglia connections via the gut–brain axis. J Exp Med 2019;216:41–59.

[2] Abdel-Haq R, Schlachetzki JCM, Boktor JC et al. A prebiotic diet modulates microglial states and motor deficits in α-synuclein over-expressing mice. Elife 2022;11:e81453.

[3] Adewuyi EO, O’Brien EK, Porter T et al. Relationship of cognition and Alzheimer’s Disease with gastrointestinal tract disorders: a large-scale genetic overlap and mendelian randomisation analysis. Int J Mol Sci 2022;23(24):16199.

[4] Agirman G, Yu KB, Hsiao EY. Signaling inflammation across the gut–brain axis. Science 2021;374:1087–1092.

[5] Agus A, Clément K, Sokol H. Gut microbiota-derived metabolites as central regulators in metabolic disorders. Gut 2021;70:1174–1182.

[6] Aguzzi A, Barres BA, Bennett ML. Microglia: scapegoat, saboteur, or something else? Science 2013;339:156–161.

[7] Allen JM, Mackos AR, Jaggers RM et al. Psychological stress disrupts intestinal epithelial cell function and mucosal integrity through microbe and host-directed processes. Gut Microbes 2022;14:2035661.

[8] Araujo DM, Cotman CW. Basic FGF in astroglial, microglial, and neuronal cultures: characterization of binding sites and modulation of release by lymphokines and trophic factors. J Neurosci 1992;12:1668–1678.

[9] Atmani K, Wuestenberghs F, Baron M et al. Bladder-colon chronic cross-sensitization involves neuro-glial pathways in male mice. World J Gastroenterol 2022;28:6935–6949.

[10] Badimon A, Strasburger HJ, Ayata P et al. Negative feedback control of neuronal activity by microglia. Nature 2020;586:417–423.

[11] Balemans D, Aguilera-Lizarraga J, Florens MV et al. Histamine-mediated potentiation of transient receptor potential (TRP) ankyrin 1 and TRP vanilloid 4 signaling in submucosal neurons in patients with irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2019;316:G338–G349.

[12] Bassett B, Subramaniyam S, Fan Y et al. Minocycline alleviates depression-like symptoms by rescuing decrease in neurogenesis in dorsal hippocampus via blocking microglia activation/phagocytosis. Brain Behav Immun 2021;91:519–530.

[13] Basso L, Lapointe TK, Iftinca M et al. Granulocyte-colonystimulating factor (G-CSF) signaling in spinal microglia drives visceral sensitization following colitis. Proc Natl Acad Sci USA 2017;114:11235–11240.

[14] Belkaid Y, Harrison OJ. Homeostatic immunity and the microbiota. Immunity 2017;46:562–576.

[15] Bhargava P, Smith MD, Mische L et al. Bile acid metabolism is altered in multiple sclerosis and supplementation ameliorates neuroinflammation. J Clin Invest 2020;130:3467–3482.

[16] Black CJ, Drossman DA, Talley NJ et al. Functional gastrointestinal disorders: advances in understanding and management. Lancet 2020a;396:1664–1674.

[17] Black CJ, Yuan Y, Selinger CP et al. Efficacy of soluble fibre, antispasmodic drugs, and gut–brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis. Lancet Gastroenterol Hepatol 2020b;5:117–131.

[18] Blandino P Jr, Barnum CJ, Deak T. The involvement of norepinephrine and microglia in hypothalamic and splenic IL-1beta responses to stress. J Neuroimmunol 2006;173:87–95.

[19] Bravo JA, Forsythe P, Chew MV et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci USA 2011;108:16050–16055.

[20] Brawner KM, Yeramilli VA, Kennedy BA et al. Prenatal stress increases IgA coating of offspring microbiota and exacerbates necrotizing enterocolitis-like injury in a sex-dependent manner. Brain Behav Immun 2020;89:291–299.

[21] Brown DG, Soto R, Yandamuri S et al. The microbiota protects from viral-induced neurologic damage through microglia-intrinsic TLR signaling. Elife 2019;8:e47117.

[22] Castellano B, Bosch-Queralt M, Almolda B et al. Purine signaling and microglial wrapping. Adv Exp Med Biol 2016;949:147–165.

[23] Cheadle L, Rivera SA, Phelps JS et al. Sensory experience engages microglia to shape neural connectivity through a non-phagocytic mechanism. Neuron 2020;108:451–468.e9.

[24] Chen CH, Lin CL, Kao CH. Irritable bowel syndrome is associated with an increased risk of dementia: a Nationwide Population-Based Study. PLoS One 2016;11:e0144589.

[25] Chen C, Liao J, Xia Y et al. Gut microbiota regulate Alzheimer’s disease pathologies and cognitive disorders via PUFA-associated neuroinflammation. Gut 2022a;71:2233–2252.

[26] Chen J, Zhao BC, Dai XY et al. Drinking alkaline mineral water confers diarrhea resistance in maternally separated piglets by maintaining intestinal epithelial regeneration via the brain–microbe–gut axis. J Adv Res 2022b;S2090-1232(22)00287-9.

[27] Cohen SM, Tsien RW, Goff DC et al. The impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophrenia. Schizophr Res 2015;167:98–107.

[28] Cox LM, Calcagno N, Gauthier C et al. The microbiota restrains neurodegenerative microglia in a model of amyotrophic lateral sclerosis. Microbiome 2022;10:47.

[29] Cryan JF, O’Riordan KJ, Cowan CSM et al. The microbiota–gut–brain axis. Physiol Rev 2019;99:1877–2013.

[30] Cunningham CL, Martínez-Cerdeño V, Noctor SC. Microglia regulate the number of neural precursor cells in the developing cerebral cortex. J Neurosci 2013;33:4216–4233.

[31] Damisah EC, Hill RA, Rai A et al. Astrocytes and microglia play orchestrated roles and respect phagocytic territories during neuronal corpse removal in vivo. Sci Adv 2020;6:eaba3239.

[32] Davalos D, Grutzendler J, Yang G et al. ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 2005;8:752–758.

[33] Defaye M, Abdullah NS, Iftinca M et al. Gut-innervating TRPV1+ neurons drive chronic visceral pain via microglial P2Y12 receptor. Cell Mol Gastroenterol Hepatol 2022;13:977–999.

[34] De Palma G, Shimbori C, Reed DE et al. Histamine production by the gut microbiota induces visceral hyperalgesia through histamine 4 receptor signaling in mice. Sci Transl Med 2022;14:eabj1895.

[35] Ding X, Wang J, Huang M et al. Loss of microglial SIRPα promotes synaptic pruning in preclinical models of neurodegeneration. Nat Commun 2021;12:2030.

[36] Dionisio-Santos DA, Olschowka JA, O’Banion MK. Exploiting micro-glial and peripheral immune cell crosstalk to treat Alzheimer’s disease. J Neuroinflammation 2019;16:74.

[37] Dodiya HB, Kuntz T, Shaik SM et al. Sex-specific effects of microbiome perturbations on cerebral Aβ amyloidosis and microglia phenotypes. J Exp Med 2019;216:1542–1560.

[38] Domínguez-Punaro MC, Segura M, Plante MM et al. Streptococcus suis serotype 2, an important swine and human pathogen, induces strong systemic and cerebral inflammatory responses in a mouse model of infection. J Immunol 2007;179:1842–1854.

[39] Drossman DA, Hasler WL. Rome IV-functional GI disorders: disorders of gut–brain interaction. Gastroenterology 2016;150:1257–1261.

[40] Duan R, Zhu S, Wang B et al. Alterations of gut microbiota in patients with irritable bowel syndrome based on 16S rRNA-targeted sequencing: a systematic review. Clin Transl Gastroenterol 2019;10:e00012.

[41] El-Salhy M, Hatlebakk JG, Gilja OH et al. Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study. Gut 2020;69:859–867.

[42] Erny D, Hrabě de Angelis AL, Jaitin D et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci 2015;18:965–977.

[43] Erny D, Dokalis N, Mezö C et al. Microbiota-derived acetate enables the metabolic fitness of the brain innate immune system during health and disease. Cell Metab 2021;33:2260–2276.e7.

[44] Fang Y, Zhang J, Zhu S et al. Berberine ameliorates ovariectomy-induced anxiety-like behaviors by enrichment in equol generating gut microbiota. Pharmacol Res 2021;165:105439.

[45] Filipello F, Morini R, Corradini I et al. The microglial innate immune receptor TREM2 is required for synapse elimination and normal brain connectivity. Immunity 2018;48:979–991.e8.

[46] Fond G, Loundou A, Hamdani N et al. Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis. Eur Arch Psychiatry Clin Neurosci 2014;264:651–660.

[47] Ford AC, Quigley EM, Lacy BE et al. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. Am J Gastroenterol 2014;109:1547–61; quiz 1546, 1562.

[48] Frank MG, Fonken LK, Dolzani SD et al. Immunization with Mycobacterium vaccae induces an anti-inflammatory milieu in the CNS: attenuation of stress-induced microglial priming, alarmins and anxiety-like behavior. Brain Behav Immun 2018;73:352–363.

[49] Fu P, Gao M, Yung KKL. Association of intestinal disorders with Parkinson’s disease and Alzheimer’s disease: a systematic review and meta-analysis. ACS Chem Neurosci 2020;11:395–405.

[50] Funk KE, Klein RS. CSF1R antagonism limits local restimulation of antiviral CD8(+) T cells during viral encephalitis. J Neuroinflamm 2019;16:22.

[51] Galley JD, Mashburn-Warren L, Blalock LC et al. Maternal anxiety, depression and stress affects offspring gut microbiome diversity and bifidobacterial abundances. Brain Behav Immun 2023;107:253–264.

[52] Garber C, Soung A, Vollmer LL et al. T cells promote microglia-mediated synaptic elimination and cognitive dysfunction during recovery from neuropathogenic flaviviruses. Nat Neurosci 2019;22:1276–1288.

[53] George S, Rey NL, Tyson T et al. Microglia affect α-synuclein cell-to-cell transfer in a mouse model of Parkinson’s disease. Mol Neurodegener 2019;14:34.

[54] Goehler LE, Gaykema RP, Opitz N et al. Activation in vagal afferents and central autonomic pathways: early responses to intestinal infection with Campylobacter jejuni. Brain Behav Immun 2005;19:334–344.

[55] Gunner G, Cheadle L, Johnson KM et al. Sensory lesioning induces microglial synapse elimination via ADAM10 and fractalkine signaling. Nat Neurosci 2019;22:1075–1088.

[56] Gupta S, Ellis SE, Ashar FN et al. Transcriptome analysis reveals dysregulation of innate immune response genes and neuronal activity-dependent genes in autism. Nat Commun 2014;5:5748.

[57] Hoffmann O, Mahrhofer C, Rueter N et al. Pneumococcal cell wall-induced meningitis impairs adult hippocampal neurogenesis. Infect Immun 2007a;75:4289–4297.

[58] Hoffmann O, Braun JS, Becker D et al. TLR2 mediates neuroinflammation and neuronal damage. J Immunol 2007b;178:6476–6481.

[59] Huaman JW, Mego M, Manichanh C et al. Effects of prebiotics vs a diet low in FODMAPs in patients with functional gut disorders. Gastroenterology 2018;155:1004–1007.

[60] Huang M, He Y, Tian L et al. Gut microbiota–SCFAs–brain axis associated with the antidepressant activity of berberine in CUMS rats. J Affect Disord 2023;325:141–150.

[61] Ivanov II, Atarashi K, Manel N et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009;139:485–498.

[62] Jacobs JP, Lagishetty V, Hauer MC et al. Multi-omics profiles of the intestinal microbiome in irritable bowel syndrome and its bowel habit subtypes. Microbiome 2023;11:5.

[63] Jalanka-Tuovinen J, Salojärvi J, Salonen A et al. Faecal microbiota composition and host-microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome. Gut 2014;63:1737–1745.

[64] Ji NN, Meng QX, Wang Y et al. Microglia-derived TNF-α inhibiting GABAergic neurons in the anterior lateral bed nucleus of the stria terminalis precipitates visceral hypersensitivity induced by colorectal distension in rats. Neurobiol Stress 2022;18:100449.

[65] Jia X, Gao Z, Hu H. Microglia in depression: current perspectives. Sci China Life Sci 2021;64:911–925.

[66] Johnsen PH, Hilpüsch F, Cavanagh JP et al. Faecal microbiota trans-plantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial. Lancet Gastroenterol Hepatol 2018;3:17–24.

[67] Johnson JD, Campisi J, Sharkey CM et al. Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines. Neuroscience 2005;135:1295–1307.

[68] Karl JP, Margolis LM, Madslien EH et al. Changes in intestinal micro-biota composition and metabolism coincide with increased intestinal permeability in young adults under prolonged physiological stress. Am J Physiol Gastrointest Liver Physiol 2017;312:G559–G571.

[69] Kielian T. Immunopathogenesis of brain abscess. J Neuroinflamm 2004;1:16.

[70] Knowles SR, Nelson EA, Palombo EA. Investigating the role of perceived stress on bacterial flora activity and salivary cortisol secretion: a possible mechanism underlying susceptibility to illness. Biol Psychol 2008;77:132–137.

[71] Lai NY, Musser MA, Pinho-Ribeiro FA et al. Gut-innervating nociceptor neurons regulate Peyer’s patch microfold cells and SFB levels to mediate Salmonella host defense. Cell 2020;180:33–49.e22.

[72] Larsson MB, Tillisch K, Craig AD et al. Brain responses to visceral stimuli reflect visceral sensitivity thresholds in patients with irritable bowel syndrome. Gastroenterology 2012;142:463–472.e3.

[73] Lebovitz Y, Kowalski EA, Wang X et al. Lactobacillus rescues postnatal neurobehavioral and microglial dysfunction in a model of maternal microbiome dysbiosis. Brain Behav Immun 2019;81:617–629.

[74] Lee EJ, Woo MS, Moon PG et al. Alpha-synuclein activates microglia by inducing the expressions of matrix metalloproteinases and the subsequent activation of protease-activated receptor-1. J Immunol 2010;185:615–623.

[75] Lee AS, Azmitia EC, Whitaker-Azmitia PM. Developmental microglial priming in postmortem autism spectrum disorder temporal cortex. Brain Behav Immun 2017;62:193–202.

[76] Lehnardt S, Henneke P, Lien E et al. A mechanism for neurodegeneration induced by group B streptococci through activation of the TLR2/MyD88 pathway in microglia. J Immunol 2006;177:583–592.

[77] Lembo A, Pimentel M, Rao SS et al. Repeat treatment with rifaximin is safe and effective in patients with diarrhea-predominant irritable bowel syndrome. Gastroenterology 2016;151:1113–1121.

[78] Li E, Noda M, Doi Y et al. The neuroprotective effects of milk fat globule-EGF factor 8 against oligomeric amyloid β toxicity. J Neuroinflamm 2012;9:148.

[79] Li B, Lee C, Filler T et al. Inhibition of corticotropin-releasing hormone receptor 1 and activation of receptor 2 protect against colonic injury and promote epithelium repair. Sci Rep 2017;7:46616.

[80] Li Q, Chen L, Liu X et al. Pterostilbene inhibits amyloid-β-induced neuroinflammation in a microglia cell line by inactivating the NLRP3/caspase-1 inflammasome pathway. J Cell Biochem 2018;119:7053–7062.

[81] Li H, Xiang Y, Zhu Z et al. Rifaximin-mediated gut microbiota regulation modulates the function of microglia and protects against CUMS-induced depression-like behaviors in adolescent rat. J Neuroinflamm 2021;18:254.

[82] Li F, Wang Y, Song X et al. The intestinal microbial metabolite nicotinamide n-oxide prevents herpes simplex encephalitis via activating mitophagy in microglia. Gut Microbes 2022a;14:2096989.

[83] Li C, Zhu L, Dai Y et al. Diet-induced high serum levels of trimethylamine-N-oxide enhance the cellular inflammatory response without exacerbating acute intracerebral hemorrhage injury in mice. Oxid Med Cell Longev 2022b;2022:1599747.

[84] Li J, Li Y, Duan W et al. Shugan granule contributes to the improvement of depression-like behaviors in chronic restraint stress-stimulated rats by altering gut microbiota. CNS Neurosci Ther 2022c;28:1409–1424.

[85] Li F, Wang Y, Zheng K. Microglial mitophagy integrates the microbiota–gut–brain axis to restrain neuroinflammation during neurotropic herpesvirus infection. Autophagy 2023a;19:734–736.

[86] Li Z, Chen K, Shao Q et al. Nanoparticulate MgH(2) ameliorates anxiety/depression-like behaviors in a mouse model of multiple sclerosis by regulating microglial polarization and oxidative stress. J Neuroinflamm 2023b;20:16.

[87] Li C, Liu B, Xu J et al. Phloretin decreases microglia-mediated synaptic engulfment to prevent chronic mild stress-induced depression- like behaviors in the mPFC. Theranostics 2023c;13:955–972.

[88] Lin CH, Chen CC, Chiang HL et al. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson’s disease. J Neuroinflamm 2019;16:129.

[89] Liu Y, Zhang L, Wang X et al. Similar fecal microbiota signatures in patients with diarrhea-predominant irritable bowel syndrome and patients with depression. Clin Gastroenterol Hepatol 2016;14:1602–1611.e5.

[90] Liu Z, Zhu S, He M et al. Patients with breath test positive are necessary to be identified from irritable bowel syndrome: a clinical trial based on microbiomics and rifaximin sensitivity. Chin Med J (Engl) 2022;135:1716–1727.

[91] Lu S, Jiang HY, Shi YD. Association between irritable bowel syndrome and Parkinson’s disease: a systematic review and meta-analysis. Acta Neurol Scand 2022;145:442–448.

[92] Lucarini E, Parisio C, Branca JJV et al. Deepening the mechanisms of visceral pain persistence: an evaluation of the gut–spinal cord relationship. Cells 2020;9:1772.

[93] Ma N, Zhang J, Reiter RJ et al. Melatonin mediates mucosal immune cells, microbial metabolism, and rhythm crosstalk: a therapeutic target to reduce intestinal inflammation. Med Res Rev 2020;40:606–632.

[94] Margolis KG, Cryan JF, Mayer EA. The microbiota–gut–brain axis: from motility to mood. Gastroenterology 2021;160:1486–1501.

[95] Mars RAT, Yang Y, Ward T et al. Longitudinal multi-omics reveals subset-specific mechanisms underlying irritable bowel syndrome. Cell 2020;182:1460–1473.e17.

[96] Matcovitch-Natan O, Winter DR, Giladi A et al. Microglia development follows a stepwise program to regulate brain homeostasis. Science 2016;353:aad8670.

[97] Mayer EA, Nance K, Chen S. The gut–brain axis. Annu Rev Med 2022;73:439–453.

[98] McIntosh K, Reed DE, Schneider T et al. FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial. Gut 2017;66:1241–1251.

[99] McMillin M, Frampton G, Grant S et al. Bile acid-mediated Sphingosine-1-Phosphate receptor 2 signaling promotes neuroinflammation during hepatic encephalopathy in mice. Front Cell Neurosci 2017;11:191.

[100] Meng F, Li N, Li D et al. The presence of elevated circulating trimethylamine N-oxide exaggerates postoperative cognitive dysfunction in aged rats. Behav Brain Res 2019;368:111902.

[101] Moehle MS, Webber PJ, Tse T et al. LRRK2 inhibition attenuates microglial inflammatory responses. J Neurosci 2012;32:1602–1611.

[102] Moonen S, Koper MJ, Van Schoor E et al. Pyroptosis in Alzheimer’s disease: cell type-specific activation in microglia, astrocytes and neurons. Acta Neuropathol 2023;145:175–195.

[103] Moseman EA, Blanchard AC, Nayak D et al. T cell engagement of cross-presenting microglia protects the brain from a nasal virus infection. Sci Immunol 2020;5(48):eabb1817.

[104] Mossad O, Batut B, Yilmaz B et al. Gut microbiota drives age-related oxidative stress and mitochondrial damage in microglia via the metabolite N(6)-carboxymethyllysine. Nat Neurosci 2022;25:295–305.

[105] Mujagic Z, Kasapi M, Jonkers DM et al. Integrated fecal microbiome-metabolome signatures reflect stress and serotonin metabolism in irritable bowel syndrome. Gut Microbes 2022;14:2063016.

[106] Nakajima K, Honda S, Tohyama Y et al. Neurotrophin secretion from cultured microglia. J Neurosci Res 2001;65:322–331.

[107] Nakitanda AO, Kieler H, Odsbu I et al. In-utero antibiotic exposure and subsequent infections in infancy: A register-based cohort study with si,bling analysis. Am J Obstet Gynecol MFM 2023;5(4):100860.

[108] Nayak D, Roth TL, McGavern DB. Microglia development and function. Annu Rev Immunol 2014;32:367–402.

[109] Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005;308:1314–1318.

[110] Paolicelli RC, Bolasco G, Pagani F et al. Synaptic pruning by microglia is necessary for normal brain development. Science 2011;333:1456–1458.

[111] Parker A, Fonseca S, Carding SR. Gut microbes and metabolites as modulators of blood–brain barrier integrity and brain health. Gut Microbes 2020;11:135–157.

[112] Perna E, Aguilera-Lizarraga J, Florens MV et al. Effect of resolvins on sensitisation of TRPV1 and visceral hypersensitivity in IBS. Gut 2021;70:1275–1286.

[113] Picard K, Bisht K, Poggini S et al. Microglial-glucocorticoid receptor depletion alters the response of hippocampal microglia and neurons in a chronic unpredictable mild stress paradigm in female mice. Brain Behav Immun 2021;97:423–439.

[114] Pimentel M, Lembo A, Chey WD et al; TARGET Study Group. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med 2011;364:22–32.

[115] Pinto-Sanchez MI, Hall GB, Ghajar K et al. Probiotic Bifidobacterium longum NCC3001 reduces depression scores and alters brain activity: a Pilot Study in patients with irritable bowel syndrome. Gastroenterology 2017;153:448–459.e8.

[116] Prinz M, Kann O, Draheim HJ et al. Microglial activation by components of Gram-positive and -negative bacteria: distinct and common routes to the induction of ion channels and cytokines. J Neuropathol Exp Neurol 1999;58:1078–1089.

[117] Rao S, Schieber AMP, O’Connor CP et al. Pathogen-mediated inhibition of anorexia promotes host survival and transmission. Cell 2017;168:503–516.e12.

[118] Ribeiro Xavier AL, Kress BT, Goldman SA et al. A distinct population of microglia supports adult neurogenesis in the subventricular zone. J Neurosci 2015;35:11848–11861.

[119] Ribes S, Ebert S, Regen T et al. Toll-like receptor stimulation enhances phagocytosis and intracellular killing of nonencapsulated and encapsulated Streptococcus pneumoniae by murine microglia. Infect Immun 2010;78:865–871.

[120] Rothhammer V, Borucki DM, Tjon EC et al. Microglial control of astrocytes in response to microbial metabolites. Nature 2018;557:724–728.

[121] Saffouri GB, Shields-Cutler RR, Chen J et al. Small intestinal microbial dysbiosis underlies symptoms associated with functional gastrointestinal disorders. Nat Commun 2019;10:2012.

[122] Schmidt EKA, Raposo PJF, Torres-Espin A et al. Beyond the lesion site: minocycline augments inflammation and anxiety-like behavior following SCI in rats through action on the gut microbiota. J Neuroinflamm 2021;18:144.

[123] Schmidtner AK, Slattery DA, Gläsner J et al. Minocycline alters behavior, microglia and the gut microbiome in a trait-anxiety-dependent manner. Transl Psychiatry 2019;9:223.

[124] Shaler CR, Parco AA, Elhenawy W et al. Psychological stress impairs IL22-driven protective gut mucosal immunity against colonising pathobionts. Nat Commun 2021;12:6664.

[125] Shan S, Hong-Min T, Yi F et al. New evidences for fractalkine/CX3CL1 involved in substantia nigral microglial activation and behavioral changes in a rat model of Parkinson’s disease. Neurobiol Aging 2011;32:443–458.

[126] Shao J, Ma X, Qu L et al. Ginsenoside Rh4 remodels the periphery microenvironment by targeting the brain–gut axis to alleviate depression-like behaviors. Food Chem 2023;404:134639.

[127] Sharma RK, Yang T, Oliveira AC et al. Microglial cells impact gut microbiota and gut pathology in angiotensin II-induced hypertension. Circ Res 2019;124:727–736.

[128] Shen J, Guo H, Liu S et al. Aberrant branched-chain amino acid accumulation along the microbiota–gut–brain axis: crucial targets affecting the occurrence and treatment of ischaemic stroke. Br J Pharmacol 2023;180:347–368.

[129] Silva YP, Bernardi A, Frozza RL. The role of short-chain fatty acids from gut microbiota in gut–brain communication. Front Endocrinol (Lausanne) 2020;11:25.

[130] Simrén M, Barbara G, Flint HJ et al; Rome Foundation Committee. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut 2013;62:159–176.

[131] Sipe GO, Lowery RL, Tremblay M et al. Microglial P2Y12 is necessary for synaptic plasticity in mouse visual cortex. Nat Commun 2016;7:10905.

[132] Song L, He M, Sun Q et al. Roseburia hominis increases intestinal melatonin level by activating p-CREB-AANAT pathway. Nutrients 2021;14:117.

[133] Song L, Sun Q, Zheng H et al. Roseburia hominis alleviates neuroinflammation via short-chain fatty acids through histone deacetylase inhibition. Mol Nutr Food Res 2022;66:e2200164.

[134] Sosna J, Philipp S, Albay R 3rd et al. Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer’s disease. Mol Neurodegener 2018;13:11.

[135] Spangenberg EE, Lee RJ, Najafi AR et al. Eliminating microglia in Alzheimer’s mice prevents neuronal loss without modulating amyloid-β pathology. Brain 2016;139:1265–1281.

[136] Sperber AD, Bangdiwala SI, Drossman DA et al. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation Global Study. Gastroenterology 2021;160:99–114.e3.

[137] Staudacher HM, Irving PM, Lomer MC et al. Mechanisms and efficacy of dietary FODMAP restriction in IBS. Nat Rev Gastroenterol Hepatol 2014;11:256–266.

[138] Stefanatos R, Sanz A. The role of mitochondrial ROS in the aging brain. FEBS Lett 2018;592:743–758.

[139] Stefani J, Tschesnokowa O, Parrilla M et al. Disruption of the microglial ADP receptor P2Y(13) enhances adult hippocampal neurogenesis. Front Cell Neurosci 2018;12:134.

[140] Streit WJ. Microglial senescence: does the brain’s immune system have an expiration date? Trends Neurosci 2006;29:506–510.

[141] Sun J, Li H, Jin Y et al. Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson’s disease via gut microbiota-GLP-1 pathway. Brain Behav Immun 2021;91:703–715.

[142] Sundman MH, Chen NK, Subbian V et al. The bidirectional gut–brain–microbiota axis as a potential nexus between traumatic brain injury, inflammation, and disease. Brain Behav Immun 2017;66:31–44.

[143] Suzuki K, Sugihara G, Ouchi Y et al. Microglial activation in young adults with autism spectrum disorder. JAMA Psychiatry 2013;70:49–58.

[144] Szalay G, Martinecz B, Lénárt N et al. Microglia protect against brain injury and their selective elimination dysregulates neuronal network activity after stroke. Nat Commun 2016;7:11499.

[145] Takahashi K, Rochford CD, Neumann H. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J Exp Med 2005;201:647–657.

[146] Tay TL, Béchade C, D’Andrea I et al. Microglia gone rogue: impacts on psychiatric disorders across the lifespan. Front Mol Neurosci 2017;10:421.

[147] Teng Y, Mu J, Xu F et al. Gut bacterial isoamylamine promotes age-related cognitive dysfunction by promoting microglial cell death. Cell Host Microbe 2022;30:944–960.e8.

[148] Thion MS, Low D, Silvin A et al. Microbiome influences prenatal and adult microglia in a sex-specific manner. Cell 2018;172:500–516.e16.

[149] Tian P, Zou R, Wang L et al. Multi-probiotics ameliorate major depressive disorder and accompanying gastrointestinal syndromes via serotonergic system regulation. J Adv Res 2022;45:117–125.

[150] Torres-Platas SG, Cruceanu C, Chen GG et al. Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides. Brain Behav Immun 2014;42:50–59.

[151] Trang T, Beggs S, Salter MW. Brain-derived neurotrophic factor from microglia: a molecular substrate for neuropathic pain. Neuron Glia Biol 2011;7:99–108.

[152] Tremblay M, Lowery RL, Majewska AK. Microglial interactions with synapses are modulated by visual experience. PLoS Biol 2010;8:e1000527.

[153] Ueno M, Fujita Y, Tanaka T et al. Layer V cortical neurons require microglial support for survival during postnatal development. Nat Neurosci 2013;16:543–551.

[154] Unger MM, Spiegel J, Dillmann KU et al. Short chain fatty acids and gut microbiota differ between patients with Parkinson’s disease and age-matched controls. Parkinsonism Relat Disord 2016;32:66–72.

[155] VanRyzin JW, Marquardt AE, Argue KJ et al. Microglial phagocytosis of newborn cells is induced by endocannabinoids and sculpts sex differences in juvenile rat social play. Neuron 2019;102:435–449.e6.

[156] Wake H, Moorhouse AJ, Jinno S et al. Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J Neurosci 2009;29:3974–3980.

[157] Wakselman S, Béchade C, Roumier A et al. Developmental neuronal death in hippocampus requires the microglial CD11b integrin and DAP12 immunoreceptor. J Neurosci 2008;28:8138–8143.

[158] Wang B, Zhu S, Liu Z et al. Increased expression of colonic mucosal melatonin in patients with irritable bowel syndrome correlated with gut dysbiosis. Genomics Proteom Bioinform 2020;18:708–720.

[159] Wang X, Wang Z, Cao J et al. Gut microbiota-derived metabolites mediate the neuroprotective effect of melatonin in cognitive impairment induced by sleep deprivation. Microbiome 2023a;11:17.

[160] Wang J, Chen HS, Li HH et al. Microglia-dependent excessive synaptic pruning leads to cortical underconnectivity and behavioral abnormality following chronic social defeat stress in mice. Brain Behav Immun 2023b;109:23–36.

[161] Wei H, Yu C, Zhang C et al. Butyrate ameliorates chronic alcoholic central nervous damage by suppressing microglia-mediated neuroinflammation and modulating the microbiome–gut–brain axis. Biomed Pharmacother 2023;160:114308.

[162] Wheeler DL, Sariol A, Meyerholz DK et al. Microglia are required for protection against lethal coronavirus encephalitis in mice. J Clin Invest 2018;128:931–943.

[163] Wilder-Smith CH. The balancing act: endogenous modulation of pain in functional gastrointestinal disorders. Gut 2011;60:1589–1599.

[164] Wolf SA, Boddeke HW, Kettenmann H. Microglia in physiology and disease. Annu Rev Physiol 2017;79:619–643.

[165] Wouters MM, Balemans D, Van Wanrooy S et al. Histamine receptor H1-mediated sensitization of TRPV1 mediates visceral hypersensitivity and symptoms in patients with irritable bowel syndrome. Gastroenterology 2016;150:875–87.e9.

[166] Yamagata T, Muroya K, Mukasa T et al. Hepatocyte growth factor specifically expressed in microglia activated Ras in the neurons, similar to the action of neurotrophic factors. Biochem Biophys Res Commun 1995;210:231–237.

[167] Yang L, Liu C, Li W et al. Depression-like behavior associated with E/I imbalance of mPFC and amygdala without TRPC channels in mice of knockout IL-10 from microglia. Brain Behav Immun 2021;97:68–78.

[168] Yang Y, Huang T, Zhang H et al. Formononetin improves cardiac function and depressive behaviours in myocardial infarction with depression by targeting GSK-3β to regulate macrophage/microglial polarization. Phytomedicine 2023;109:154602.

[169] Yuan T, Manohar K, Latorre R et al. Inhibition of microglial activation in the Amygdala reverses stress-induced abdominal pain in the male rat. Cell Mol Gastroenterol Hepatol 2020;10:527–543.

[170] Zhang S, Wang XJ, Tian LP et al. CD200-CD200R dysfunction exacer-bates microglial activation and dopaminergic neurodegeneration in a rat model of Parkinson’s disease. J Neuroinflammation 2011;8:154.

[171] Zhang G, Yu L, Chen ZY et al. Activation of corticotropin-releasing factor neurons and microglia in paraventricular nucleus precipitates visceral hypersensitivity induced by colorectal distension in rats. Brain Behav Immun 2016;55:93–104.

[172] Zhang L, Liu YX, Wang Z et al. Clinical characteristic and fecal microbiota responses to probiotic or antidepressant in patients with diarrhea-predominant irritable bowel syndrome with depression comorbidity: a pilot study. Chin Med J (Engl) 2019a;132:346–351.

[173] Zhang J, Song L, Wang Y et al. Beneficial effect of butyrate-producing Lachnospiraceae on stress-induced visceral hypersensitivity in rats. J Gastroenterol Hepatol 2019b;34:1368–1376.

[174] Zhang JD, Liu J, Zhu SW et al. Berberine alleviates visceral hyper-sensitivity in rats by altering gut microbiome and suppressing spinal microglial activation. Acta Pharmacol Sin 2021;42:1821–1833.

[175] Zhang T, Zhang C, Zhang J et al. Efficacy of probiotics for irritable bowel syndrome: a systematic review and network meta-analysis. Front Cell Infect Microbiol 2022a;12:859967.

[176] Zhang Y, Zhang J, Duan L. The role of microbiota-mitochondria crosstalk in pathogenesis and therapy of intestinal diseases. Pharmacol Res 2022b;186:106530.

[177] Zhao Y, Wu X, Li X et al. TREM2 Is a Receptor for β-amyloid that mediates microglial function. Neuron 2018;97:1023–1031.e7.

[178] Zheng G, Wu SP, Hu Y et al. Corticosterone mediates stress-related increased intestinal permeability in a region-specific manner. Neurogastroenterol Motil 2013;25:e127–e139.

[179] Zhou R, Qian S, Cho WCS et al. Microbiota-microglia connections in age-related cognition decline. Aging Cell 2022;21:e13599.

[180] Zhu H, Bai Y, Wang G et al. Hyodeoxycholic acid inhibits lipopolysaccharide-induced microglia inflammatory responses through regulating TGR5/AKT/NF-κB signaling pathway. J Psychopharmacol 2022;36:849–859.

[181] Ziv Y, Avidan H, Pluchino S et al. Synergy between immune cells and adult neural stem/progenitor cells promotes functional recovery from spinal cord injury. Proc Natl Acad Sci USA 2006;103:13174–13179.

RIGHTS & PERMISSIONS

2023 The Author(s) 2023. Published by Oxford University Press on behalf of Higher Education Press.